https://www.selleckchem.com/pr....oducts/jnj-64619178.
n-muscle-invasive bladder cancer are treated with bacillus Calmette-Guérin to prevent recurrence and progression. This is associated with significant side effects. We report the results of a clinical trial showing a reduction in the number of instillations (from 15 to nine in total) being inferior to the standard protocol. From today's perspective, complete tumour resection and a standard number of instillations remain the standard of care.HCC is a highly lethal malignancy with Sorafenib as the only molecularly targeted drug. The m
Like
Comment
Share
